Nevro Corp (NVRO)

4.52 +0.16 (+3.67%) USD  |  NYSE  |  Nov 22, 16:00
4.515 0.00 (0.00%) Pre-Market: 20:00
More

Nevro Research and Development Expense (Quarterly): 10.58M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
September 30, 2024 10.58M
June 30, 2024 14.12M
March 31, 2024 14.83M
December 31, 2023 12.42M
September 30, 2023 13.92M
June 30, 2023 13.32M
March 31, 2023 14.76M
December 31, 2022 13.95M
September 30, 2022 14.03M
June 30, 2022 12.55M
March 31, 2022 12.54M
December 31, 2021 12.71M
September 30, 2021 11.55M
June 30, 2021 11.87M
March 31, 2021 11.53M
December 31, 2020 11.83M
September 30, 2020 11.11M
June 30, 2020 10.44M
March 31, 2020 12.21M
December 31, 2019 16.93M
September 30, 2019 13.02M
June 30, 2019 14.93M
March 31, 2019 14.14M
Date Value
December 31, 2018 13.48M
September 30, 2018 12.48M
June 30, 2018 11.42M
March 31, 2018 11.08M
December 31, 2017 9.943M
September 30, 2017 9.381M
June 30, 2017 9.537M
March 31, 2017 8.699M
December 31, 2016 11.28M
September 30, 2016 7.923M
June 30, 2016 8.169M
March 31, 2016 6.361M
December 31, 2015 5.874M
September 30, 2015 5.247M
June 30, 2015 5.263M
March 31, 2015 4.998M
December 31, 2014 4.742M
September 30, 2014 5.236M
June 30, 2014 5.15M
March 31, 2014 4.696M
December 31, 2013 4.638M
September 30, 2013 4.586M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

10.44M
Minimum
Jun 2020
16.93M
Maximum
Dec 2019
12.86M
Average
12.54M
Median

Research and Development Expense (Quarterly) Benchmarks

Inspire Medical Systems Inc 26.08M
Inari Medical Inc 29.43M
Stereotaxis Inc 2.454M
Electromed Inc 0.166M
Myomo Inc 1.249M